Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

23

Number of overlapping holdings

82.1%

% of PBE's 28 holdings also in IBB

10.3%

% of IBB's 260 holdings also in PBE

Overlap by Weight
Sector Drift (PBE minus IBB)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PBE
Weight
in IBB
Overlap
GILEAD SCIENCES INC 5.3% 8.6% 5.3%
AMGEN INC 5.0% 8.4% 5.0%
REGENERON PHARMACEUTICALS 4.4% 7.2% 4.4%
NATERA INC 5.4% 2.3% 2.3%
BIOGEN IDEC INC 4.7% 2.1% 2.1%

Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to IBB
TG THERAPEUTICS INC 4.0%
NEUROCRINE BIOSCIENCES INC 3.7%
PROTAGONIST THERAPEUTICS, INC. 3.7%
CATALYST PHARMACEUTICAL PART 3.3%
NATERA INC 3.0%
ROYALTY PHARMA PLC CLASS A 3.0%
UNITED THERAPEUTICS CORP 3.0%
COLLEGIUM PHARMACEUTICAL, INC. 2.9%
ILLUMINA INC 2.8%
VERACYTE INC 2.6%
PBE Underweight Relative to IBB
VERTEX PHARMACEUTICALS INC -9.6%
ALNYLAM PHARMACEUTICALS INC -3.5%
AMGEN INC -3.5%
GILEAD SCIENCES INC -3.3%
ARGENX SE ADR -3.1%
IQVIA HOLDINGS INC -3.1%
REGENERON PHARMACEUTICALS -2.9%
METTLER-TOLEDO INTERNATIONAL -2.5%
WATERS CORP -2.3%
BIONTECH SE SPONSORED ADR -2.0%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY